AAD 2020: JAK Inhibitors Could be Game Changer in Sarcoidosis and Granuloma Annulare
Dermatologist shares remarkable successes treating patients off-label with tofacitinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.